Leader in ophthalmic laser technology selects clinivation WorldView as its most comprehensive, authoritative resource for building its medical product submissions and registrations worldwide.
Framingham, MA, February 26, 2007 – clinivation, Inc. announced today that IntraLase Corporation (NASDAQ: ILSE) has selected clinivation WorldView™ Online Regulatory Intelligence solution.
“We are pleased that IntraLase has selected clinivation WorldView as their source for worldwide regulatory intelligence and procedures,” remarked Richard Morroney, R.A.C., C.Q.A., clinivation’s Vice President of Quality and Regulatory Solutions, “With customized alerts on >99% of the world markets, IntraLase will informed of important updates to the submission and approval processes,” he continued.
Clinivation WorldView is your most comprehensive, authoritative, and up-to-date resource for building all of your medical device submissions and registrations worldwide. Clinivation WorldView also interoperates with clinivation Global™ enterprise software to make building and tracking medical device submissions and registrations easier than ever before.
About IntraLase Corporation
IntraLase Corporation designs, develops and manufactures ultra-fast femtosecond ophthalmic laser technology. The IntraLase FS laser, related software, and disposable devices replace the handheld microkeratome blade traditionally used during surgery; the IntraLase FS laser is the first bladeless and most accurate modality for corneal flap creation available today.
IntraLase is in the process of commercializing applications of its technology in the treatment of corneal diseases that require corneal transplant surgery. The FS laser and disposable patient interfaces are marketed throughout the United States and in 26 other countries.
For further information, visit www.intralase.com.